Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes
BACKGROUND Fasting and NAD+-boosting compounds, including NAD+ precursor nicotinamide riboside (NR), confer antiinflammatory effects. However, the underlying mechanisms and therapeutic potential are incompletely defined.METHODS We explored the underlying biology in myeloid cells from healthy volunte...
Main Authors: | Jing Wu, Komudi Singh, Amy Lin, Allison M. Meadows, Kaiyuan Wu, Vivian Shing, Maximilian Bley, Shahin Hassanzadeh, Rebecca D. Huffstutler, Mark S. Schmidt, Luz P. Blanco, Rong Tian, Charles Brenner, Mehdi Pirooznia, Mariana J. Kaplan, Michael N. Sack |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical Investigation
2022-03-01
|
Series: | The Journal of Clinical Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1172/JCI139828 |
Similar Items
-
Inhibition of TLR8- and TLR4-induced Type I IFN induction by alcohol is different from its effects on inflammatory cytokine production in monocytes
by: Kodys Karen, et al.
Published: (2011-09-01) -
Identification and Validation of Nutrient State-Dependent Serum Protein Mediators of Human CD4<sup>+</sup> T Cell Responsiveness
by: Kim Han, et al.
Published: (2021-04-01) -
The mechanism of Langchuangding in treatment of systemic lupus erythematosus via modulating TLR7-IRF7-IFNα pathway
by: Meijiao Wang, et al.
Published: (2024-03-01) -
Overall status of Epstein-Barr virus infection, IFN-α, and TLR-7/9 in patients with Systemic Lupus Erythematosus
by: Sayed Mahdi Marashi, et al.
Published: (2021-09-01) -
Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus
by: Kei Sakata, et al.
Published: (2018-08-01)